Clinical Gastroenterology and Hepatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-09-25 1e104510m93(暂无匿称)

审稿9天就required reviews complete ，是不是悲剧了

1123 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-09-04 1e104510m93(暂无匿称)

杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表::
研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”

医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”

1075 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-03-27 毛毛们

我投的文章，已经20天了，还是选择审稿人，正常吗？

1091 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-02-26 wei834766788

谢谢分享医学生物 2015-09-14 发表::
研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”

医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”

1072 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-02-09 1de49d63m47(暂无匿称)

……12112312312313 2016-02-03 发表::
谢谢啦

12112312312313 2016-02-03 发表:: 谢谢啦

1095 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-02-03 我们都会在

谢谢啦匿名 2016-01-20 发表::
接收率：约25% 审稿时间：约1个月挺难的哎

匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎

1052 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-01-20 王二小小

审稿速度:1.0 | 投稿命中率:25.0
经验分享：挺难的哎

1128 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-01-08 曹真

审稿速度:3.0
经验分享：难度有点大

1113 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-01-08 曹真

………匿名 2016-01-08 发表::
………

匿名 2016-01-08 发表:: ………

1261 0

[GetPortalCommentsPageByObjectIdResponse(id=527584, encodeId=889552e5840c, content=审稿9天就required reviews complete ，是不是悲剧了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 25 14:29:00 CST 2016, time=2016-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526771, encodeId=b5e5526e7125, content=杂志让我上传clinical trial study protocol，这位兄弟写过吗医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1075, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf891946729, createdName=1e104510m93(暂无匿称), createdTime=Sun Sep 04 18:27:00 CST 2016, time=2016-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520788, encodeId=352e520e8800, content=我投的文章，已经20天了，还是选择审稿人，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1091, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKt8ibGpwDuX7CGf4Nf1iaeHbqWV9NQUmj1teVPeX2aMx1ic2dghlvnV2TFXibFY7SyCCAl8iaPyicrNOQA/0, createdBy=54821701295, createdName=毛毛们, createdTime=Sun Mar 27 20:38:00 CST 2016, time=2016-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519634, encodeId=69335196340c, content=谢谢分享医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, beContent=医学生物 2015-09-14 发表:: 研究方向：胃肠;肿瘤; 接收率：约25% 审稿时间：约3个月比较难中，每年接收论著偏少。经历2次大修，每次3月，小修一次1月，共7个月接收。接收后发表速度蛮快，track系统也做的很完善，实时跟踪，不愧是Gastroenterology系列。另外：为什么我的账号是Medsci翻译版“医学生物”, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1072, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 22:02:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519115, encodeId=44705191158b, content=……12112312312313 2016-02-03 发表:: 谢谢啦, beContent=12112312312313 2016-02-03 发表:: 谢谢啦, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1095, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71771686682, createdName=1de49d63m47(暂无匿称), createdTime=Tue Feb 09 18:03:00 CST 2016, time=2016-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519010, encodeId=837051901036, content=谢谢啦匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, beContent=匿名 2016-01-20 发表:: 接收率：约25% 审稿时间：约1个月挺难的哎, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1052, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=我们都会在, createdTime=Wed Feb 03 14:03:00 CST 2016, time=2016-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518588, encodeId=f7c5518588c5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：挺难的哎, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160129/IMG56AACD0352A884380.jpg, createdBy=fb1f1681544, createdName=王二小小, createdTime=Wed Jan 20 10:01:00 CST 2016, time=2016-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518151, encodeId=3ae0518151d8, content=审稿速度:3.0 经验分享：难度有点大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518150, encodeId=d0c951815087, content=………匿名 2016-01-08 发表:: ………, beContent=匿名 2016-01-08 发表:: ………, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1261, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518149, encodeId=8cfe5181490d, content=………匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, beContent=匿名 2013-10-31 发表:: 经典期刊，不太容易中标的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1061, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160108/IMG568F572F2085A8382.jpg, createdBy=6d891676296, createdName=曹真, createdTime=Fri Jan 08 15:02:00 CST 2016, time=2016-01-08, status=1, ipAttribution=)]

2016-01-08 曹真

………匿名 2013-10-31 发表::
经典期刊，不太容易中标的

匿名 2013-10-31 发表:: 经典期刊，不太容易中标的

1061 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务